lung cancer
Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases
Posted in Medicine, Science on 22nd Jul, 2024
by Alex Muller
The global clinical trial CROWN has shown that lorlatinib (Lorbrena) is significantly more effective than crizotinib (Xalkori) as the initial treatment for advanced ALK-positive non-small cell lung cancer (NSCLC).
Trials show new cancer vaccine could improve patient survival for some lung cancers by nearly half
Posted in Medicine on 13th Sep, 2023
by Alex Muller
A French biotechnology company said that its cancer vaccine was effective in decreasing the risk of death for people with some lung cancers by 41%.
Lung cancer diagnoses of UK women to outnumber men’s for first time
Posted in Medicine on 10th Jul, 2023
by Alex Muller
Lung cancer is the most common cause of cancer death in the UK, accounting for one in five of the total. It has one of the worst cancer survival rates, which is largely attributed to diagnoses at a late stage, when treatment is less likely to be effective.
7 ways we’ve influenced progress in lung cancer
Posted in Medicine, Science on 22nd Nov, 2022
by Alex Muller
Increasing focus on lung cancer research, and increased public awareness on the dangers of tobacco has helped contribute towards half a million fewer lung cancer deaths in men in the past 40 years. But we’ve still got a long way to go.
New targeted lung cancer screening programme on the horizon
Posted in Medicine, Science on 29th Sep, 2022
by Alex Muller
The UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those at high risk of the disease. This has the potential to greatly improve early diagnosis of lung cancer.